The sensitivity of gastric cancer cells to auranofin could be increased by the silencing of genes involved in autophagy [38], and BRCA1 deficiency has further been implicated to increase sensitivity of ovarian cancer cells to auranofin [39]. The gene discussed is BRCA1; the disease is ovarian carcinoma.